<DOC>
	<DOC>NCT00730249</DOC>
	<brief_summary>Investigation of efficacy of high-dose extended-release Methylphenidate in adults with ADHD, compared with a placebo</brief_summary>
	<brief_title>Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>patient treated as outpatient score of 85 or greater in IQtest (MWTB) diagnosis of ADHD according ADHSCL (DSM IV) and WRAADDS &gt; 35 points ADHD symptoms have existed since childhood (WURSk &gt;= 30) Body Mass Index &gt;= 20 and body weight &lt; 130 kg willing to eat breakfast and lunch patient is willing and able to come to the observation appointments written consent of the patient to participate in the study treatment with psychostimulants in the past two weeks before screening shift work or night work alcohol, medication or drug dependency in the past six months or manifest drug abuse diagnosis of a psychosis (SKIDI) epileptic attacks in the past EEG result which suggests epilepsy acute depressive episode according to ICD10 F32.2 and ICD10 F32.3 (BeckDepressionInventory &gt; 18) Illness with schizophrenic symptoms (SKIDI) acute manic episode, bipolar disorder(SKIDI) diagnosis of a tic disorder acute anorexia acute prominent panic disorder and generalised anxiety (SKIDI) clinically relevant kidney disorders creatinine &gt; 1,5 x upper normrange clinically relevant liver disorder SGOT and/or SGPT &gt; 2 x upper normrange pathological ECGfinding QTc &gt; 450 msec in male, QTc &gt; 470 msec in female high blood pressure (anamnesis or blood pressure &gt; 140/90 mm Hg at screening) known acclusive arterial disease angina pectoris (anamnesis or ECGfinding) cardiac arrhythmias (anamnesis or ECGfinding) KHK (anamnesis or ECGfinding) post heartattack status (anamnesis or ECGfinding) post stroke status known elevated intraocular pressure known enlarged prostates latent and manifest hyperthyreosis TSH &lt; lower normrange patient with a terminal disease (e.g. cancer) participation in a clinical study within the past 30 days participation in this study at an earlier point in time simultaneous participation in another clinical trial women of childbearing age without adequate contraception (contraceptives, intrauterine device , no sexual intercourse) pregnancy (positive pregnancy test) or lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>adult</keyword>
	<keyword>methylphenidate hydrochloride</keyword>
	<keyword>Medikinet retard</keyword>
	<keyword>controlled clinical trial</keyword>
	<keyword>safety</keyword>
	<keyword>randomized, double-blind, placebo-controlled trial</keyword>
	<keyword>treatment</keyword>
	<keyword>central nervous system stimulants</keyword>
	<keyword>therapeutic uses</keyword>
</DOC>